11 May 2022
At the meeting of 12 April 2022 the RMA:
Determined Statements of Principles (SOPs) for:
| Condition | SOPs | |
|---|---|---|
| seizure | 37/2022 | 38/2022 |
| malignant neoplasm of the thyroid gland | 39/2022 | 40/2022 |
| malignant neoplasm of the larynx | 41/2022 | 42/2022 |
| morbid obesity | 43/2022 | 44/2022 |
| sudden unexplained death | 45/2022 | 46/2022 |
These SOPs revoke the SOPs previously determined for these conditions.
Determined New Statements of Principles (SOPs) for:
| Condition | SOPs | |
|---|---|---|
| thoracic outlet syndrome | 47/2022 | 48/2022 |
Determined Amendment Statements of Principles (SOPs) for:
| Condition | SOPs | |
|---|---|---|
| diabetes mellitus | 49/2022 | 50/2022 |
| hypogonadism | 51/2022 | 52/2022 |
| hypopituitarism | 53/2022 | 54/2022 |
| sensorineural hearing loss | 55/2022 | 56/2022 |
| immune thrombocytopaenia | 57/2022 | 58/2022 |
| acute lymphoblastic leukaemia/lymphoblastic lymphoma | 59/2022 | |
The above SOPs take effect from 30 May 2022.
Summary of Changes
Decided to Undertake Consultation regarding:
| Condition | Reasons for Decision | Date for Final Decision |
|---|---|---|
| epilepsy | Intention to remove one or more factors | August 2022 |
| periodic limb movement disorder | Intention to remove one or more factors | August 2022 |
| steatohepatitis | Intention to remove one or more factors | August 2022 |
Completed Investigations
The above determinations conclude the previously advertised investigations into:
- epileptic seizure (epileptic seizure)
- immune thrombocytopaenia (focussed review - SARS-CoV-2 infection and coronavirus disease 2019 (COVID-19) vaccines)
- sensorineural hearing loss (focussed review - xylene)
- hypopituitarism (focussed review - immune checkpoint inhibitors)
- hypogonadism (focussed review - immune checkpoint inhibitors)
- diabetes mellitus (focussed review - immune checkpoint inhibitors)
- thoracic outlet syndrome
- sudden unexplained death
- morbid obesity
- malignant neoplasm of the larynx
- malignant neoplasm of the thyroid gland
- acute lymphoblastic leukaemia/lymphoblastic lymphoma (focussed review - definition of 8-hour time-weighted average (TWA))
Note:
- The investigation concerning 'epileptic seizure' has resulted in the determination of Statements of Principles concerning seizure.
New Investigations
Decided to advertise the following investigations:
- albinism
- osteogenesis imperfecta
- osteomyelitis
- osteoporosis
- Paget disease of bone
- plantar fasciitis
- pulmonary barotrauma
- rotator cuff syndrome
- seborrhoeic keratosis
- medial tibial stress syndrome (shin splints)
- soft tissue sarcoma
- tinea
- trochanteric bursitis
- von Willebrand disease
- Wilson disease
- asthma (focussed - having a sensitising exposure to an allergen)
- conjunctivitis (focussed - having a sensitising exposure to an allergen)
- allergic contact dermatitis (focussed - having a sensitising exposure to an allergen)
- neoplasm of the pituitary gland
- multiple osteochondromatosis
- Marfan syndrome
- alpha-1 antitrypsin deficiency
- anxiety disorder
- autosomal dominant polycystic kidney disease
- Charcot-Marie-Tooth disease
- decompression illness
- epicondylitis
- Gaucher disease
- haemophilia
- shingles and postherpetic neuralgia
- horseshoe kidney
- Huntington disease
- leptospirosis
- malignant neoplasm of the breast
- malignant neoplasm of the lung
- malignant neoplasm of the salivary gland
- malignant neoplasm of the small intestine
- malignant neoplasm of the testis and epididymis
- diaphragmatic hernia
The above investigation notices appear in the Government Notices Gazette of 10 May 2022.